We're now in the waning days of summer, and the Court's activity last week somewhat reflected that: two decisions and a few orders. One of those orders was for something.
11.08.2022 - Company to host webcast and conference call today at 8:30 a.m. ET MORRISVILLE, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) - Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the second quarter ended .
Caplin Point Laboratories announced that Caplin Steriles, a Subsidiary Company, has been granted final approval from the United States
Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Etomidate injection USP, 20 mg/10 ml (2 mg/ml) and 40 mg/20 ml (2 mg/ml) Single-dose vial presentations, a generic therapeutic equivalent version of (RLD), AMIDATE (Etomidate) Injection, of HOSPIRA INC. According to IQVIA (IMS Health), Etomidate injection USP had US sales data of approximately $9 million for the 12-
month period ending Oct 2020.
Caplin Steriles, has developed and filed 19 ANDAs on its own and with partners, with 11 approvals so far.
Etomidate is a general anesthetic, used for the induction of general anesthesia and for